Diabetes

Better Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Friday, December 2, 2022

The stock option was granted as an inducement material to Ms. Gomez-Thinnes becoming an employee of Better Therapeutics in accordance with Nasdaq Listing Rule 5635(c)(4).

Key Points: 
  • The stock option was granted as an inducement material to Ms. Gomez-Thinnes becoming an employee of Better Therapeutics in accordance with Nasdaq Listing Rule 5635(c)(4).
  • The stock option will have a per share exercise price equal to the closing price of a share of Better Therapeutics common stock on the Grant Date.
  • Better Therapeutics is a prescription digital therapeutics (PDT) company developing a novel form of cognitive behavioral therapy (CBT) to address the root causes of cardiometabolic diseases.
  • Better Therapeutics clinically validated mobile applications, if authorized for marketing, are intended to be prescribed by physicians and reimbursed like traditional medicines.

Life Time Fall 60day Challenge National Winners Among Thousands Entering 2022 Holiday Season Healthier and Happier

Retrieved on: 
Friday, December 2, 2022

CHANHASSEN, Minn., Dec. 2, 2022 /PRNewswire/ -- Nearly 20,000 people across the U.S. and Canada are entering the holiday season feeling happier and healthier after participating in Life Time's (NYSE: LTH) 60day Challenge. Five people have been named national winners in the challenge by a panel of Life Time coaches - taking home prizes valued at nearly $6,000.

Key Points: 
  • Five people have been named national winners in the challenge by a panel of Life Time coaches - taking home prizes valued at nearly $6,000.
  • The Life Time 60day provides daily support, resources, and motivation for anyone looking to jumpstart their wellness goals and live a healthier life.
  • He ended up losing weight, finding a support community at Life Time and has plans to enter his first pickleball tournament.
  • Amanda Monroe (Fort Worth, TX) Before the 60day Challenge, Monroe had a back injury and suffered a lot of pain.

Global Wireless Medical Device Connectivity Market to 2027 - Featuring Baxter International, Bridge-Tech Medical, Cisco Systems and Masimo Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, December 2, 2022

The report provides an overview of the global wireless medical device connectivity market and analyzes the market trends.

Key Points: 
  • The report provides an overview of the global wireless medical device connectivity market and analyzes the market trends.
  • Further, it explains the major drivers, competitive landscape, and current trends for wireless medical device connectivity solutions.
  • The report concludes with a detailed focus on the wireless medical device connectivity landscape and includes detailed profiles of the major players operating in the global wireless medical device connectivity market.
  • The scope of the study includes only wireless medical device connectivity solutions from the three available connectivity types: wired, wireless, and hybrid.

Scientists Develop 12-Hour Method to Predict Diabetes Onset in Patients Using Artificial Intelligence

Retrieved on: 
Friday, December 2, 2022

Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening and prevention tool using artificial intelligence.

Key Points: 
  • Scientists at Klick Applied Sciences have discovered a way to transform a continuous glucose monitor (CGM) into a powerful diabetes screening and prevention tool using artificial intelligence.
  • We think CGMs could be used to not just monitor diabetesbut to prevent it altogether.
  • For the study, about 600 patients who identified as healthy, prediabetic, or living with Type 2 diabetes wore a CGM device for an average of 12 days.
  • They also presented earlier findings at the 2018 International Joint Conference on Artificial Intelligence (IJCAI) in Stockholm, Sweden.

Genprex to Present at Upcoming December Investor Conference

Retrieved on: 
Friday, December 2, 2022

AUSTIN, Texas , Dec. 2, 2022 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that its Executive Vice President, General Counsel and Chief Strategy Officer, Catherine Vaczy, will be providing an overview of the Company's gene therapies for cancer and diabetes at the following investor conference in December 2022.

Key Points: 
  • Ms. Vaczy will be available for Q&A following the presentation and for in-person one-on-one meetings with investors at the RHK Disruptive Growth Conference.
  • Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes.
  • Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches.
  • You should not regard these statements as a representation or warranty by Genprex or any other person that Genprex will achieve its objectives and plans in any specified timeframe, or at all.

Journey Biosciences launches NaviDKD™ for people with diabetes to predict long-term kidney complications

Retrieved on: 
Thursday, December 1, 2022

LEBANON, N.H., Dec. 1, 2022 /PRNewswire/ -- Journey Biosciences, Inc., a biotechnology company offering biomarker-based predictive risk screening technologies for diabetes-related complications, today announced the launch of its flagship product NaviDKD.

Key Points: 
  • LEBANON, N.H., Dec. 1, 2022 /PRNewswire/ -- Journey Biosciences, Inc. , a biotechnology company offering biomarker-based predictive risk screening technologies for diabetes-related complications, today announced the launch of its flagship product NaviDKD.
  • NaviDKD, a biomarker-based blood test, proactively assesses the risk of kidney disease in people with diabetes years before clinical signs or symptoms appear.
  • Along with its proprietary Compass reporting platform, NaviDKD provides actionable insights for preventing and managing kidney complications before they occur.
  • "For the one-in-three people with diabetes who will develop diabetic kidney disease, NaviDKD provides an opportunity to fundamentally change their ultimate health outcomes," said Adam Graybill, Chief Executive Officer of Journey Biosciences.

Alan Soroka, MD, is recognized by Continental Who's Who

Retrieved on: 
Thursday, December 1, 2022

WINDSOR LOCKS, Conn., Dec. 1, 2022 /PRNewswire/ -- Alan Soroka, MD, being recognized by Continental Who's Who as a Most Trusted Physician in the Medical Field, acknowledging his exemplary work at Prime HealthCare PC.

Key Points: 
  • WINDSOR LOCKS, Conn., Dec. 1, 2022 /PRNewswire/ -- Alan Soroka, MD, being recognized by Continental Who's Who as a Most Trusted Physician in the Medical Field, acknowledging his exemplary work at Prime HealthCare PC.
  • Upon returning to the United States, he completed his residency in internal medicine at Mount Sinai Hospital.
  • Dr. Soroka is one of the founders of HealthCare PC and prides himself on taking time with his patients.
  • According to Dr. Soroka, Internal medicine is the medical specialty dealing with the prevention, diagnosis, and treatment of adult diseases.

The Wellness Coalition is Hosting Free Flu and COVID-19 Vaccine Clinics in December for a Safer Holiday Season

Retrieved on: 
Thursday, December 1, 2022

MONTGOMERY, Ala., Dec. 01, 2022 (GLOBE NEWSWIRE) -- The Wellness Coalition is hosting community COVID-19 and flu vaccine clinics in Montgomery, Tuskegee, and Pike Road during the month of December.

Key Points: 
  • MONTGOMERY, Ala., Dec. 01, 2022 (GLOBE NEWSWIRE) -- The Wellness Coalition is hosting community COVID-19 and flu vaccine clinics in Montgomery, Tuskegee, and Pike Road during the month of December.
  • The clinics will provide free vaccines for eligible River Region residents in partnership with a variety of community organizations.
  • Flu cases are up across the country this year, and Alabama has one of the highest levels of influenza outbreak, said NaSha DeRamus, COVID/Flu program coordinator for The Wellness Coalition.
  • To learn more about these vaccine clinics or when new clinics are scheduled, visit The Wellness Coalitions Facebook page: facebook.com/thewellnesscoalition.

Global Nutritional Analysis Market 2022 to 2031 - Featuring Intertek, Eurofins Scientific, Bureau Veritas and Thermo Fisher Scientific Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 1, 2022

The nutritional analysis market consists of sales of nutritional analysis products and services by entities (organizations, sole traders, and partnerships) that are used to determine the nutritional content of foods and food products.

Key Points: 
  • The nutritional analysis market consists of sales of nutritional analysis products and services by entities (organizations, sole traders, and partnerships) that are used to determine the nutritional content of foods and food products.
  • The increasing consumer awareness and change in preference for consuming healthy food is expected to propel the growth of the nutritional analysis market.
  • Therefore, the increasing consumer awareness and change in preference for consuming healthy food are driving the growth of the nutritional analysis market.
  • The countries covered in the nutritional analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Seven Leading Health Organizations Announce New Collaboration to Enhance and Support Diabetes Care in Primary Care

Retrieved on: 
Thursday, December 1, 2022

ARLINGTON, Va., Dec. 1, 2022 /PRNewswire/ -- Seven leading health associations announced a new collaboration today to support diabetes care in the primary care and family practice setting.

Key Points: 
  • ARLINGTON, Va., Dec. 1, 2022 /PRNewswire/ -- Seven leading health associations announced a new collaboration today to support diabetes care in the primary care and family practice setting.
  • "The new Primary Care Council will provide a powerful voice for all primary care clinicians on the front lines of diabetes care," said Robert A. Gabbay, MD, PhD, chief scientific and medical officer of the American Diabetes Association.
  • The Primary Care Council collaboration will focus on improving health outcomes by improving adoption of research-based standards of care, driving better health outcomes, and advancing care for people with diabetes.
  • Join the fight with us on Facebook ( American Diabetes Association ), Spanish Facebook ( Asociacin Americana de la Diabetes ),LinkedIn ( American Diabetes Association ), Twitter ( @AmDiabetesAssn ), andInstagram ( @AmDiabetesAssn ).